Biotechnology Edge

Loading Events

« All Events

  • This event has passed.

Biotechnology Edge

March 26 @ 9:30 am - March 30 @ 2:00 pm

water-pipe-51758_1920
Many highly-successful MBI graduates have made the leap from academia to industry. Nevertheless, the world of biotech, and the drug discovery pipeline in particular, can be a mystery.  The MBI is working with researchers at Amgen to illuminate the process by which new drugs are developed, tested and brought to market.
This 5-day workshop, lead by Amgen researchers, will cover key aspects of the drug discovery process, including:

  • Identifying therapeutic targets
  • Increasing efficacy and safety
  • Process development, devices and manufacturing
  • Case studies from bench to clinic

The workshop will culminate with a site-visit to the Amgen campus in Thousand Oaks.

Space is very limited on the Amgen site visit. Registrants who attend all 4 days of the workshop at UCLA will be offered priority.

 

 

Register here!!

Amgen Speakers:

Jim Johnston  Executive Director of Research
John Ferbas  Director of the Cytometry Sciences Group
Chris Paszty Scientific Director in Cardiometabolic Disorders
Kevin Graham Biologics Optimization group within Therapeutic Discovery.
Ana Minatti leads a team of Medicinal Chemists working in the field of Cardiometabolic Disorders.
Graeme Moffat Executive Director, Preclinical
Winnie Sohn Principal Scientist in the Clinical Pharmacology, Modeling & Simulation group.
Paul Hughes Oncology Research group
Linda Narhi Scientific Executive Director in Process Development. Linda is also the director of the Amgen Postdoc Program and academic outreach.
Maria Victoria Silva Elipe NMR leader in structure elucidation in the Attribute Sciences Department

Schedule:

Monday- Thursday, March 26th-29th
9.30am-12.30pm
Boyer Hall 159

Friday March 30th
Bus to Amgen leaves from UCLA, at 7.30am
Estimated return 2-2.30pm.

Full itinerary here

Details

Start:
March 26 @ 9:30 am
End:
March 30 @ 2:00 pm
Event Category:

Venue

159 Boyer Hall

Organizers

Molecular Biology Institute
Amgen Inc.